Emerald Mutual Fund Advisers Trust Has $736,000 Position in Rxo Inc $RXO

Emerald Mutual Fund Advisers Trust cut its stake in shares of Rxo Inc (NYSE:RXO) by 88.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 47,836 shares of the company’s stock after selling 379,293 shares during the period. Emerald Mutual Fund Advisers Trust’s holdings in RXO were worth $736,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in RXO. Geneos Wealth Management Inc. acquired a new stake in shares of RXO during the 1st quarter valued at $30,000. AlphaQuest LLC purchased a new stake in shares of RXO during the second quarter worth $29,000. CWM LLC boosted its position in RXO by 141.6% during the third quarter. CWM LLC now owns 4,231 shares of the company’s stock valued at $65,000 after purchasing an additional 2,480 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in RXO by 34.1% in the second quarter. Nisa Investment Advisors LLC now owns 4,576 shares of the company’s stock valued at $72,000 after purchasing an additional 1,163 shares in the last quarter. Finally, Strs Ohio purchased a new position in RXO in the first quarter valued at about $97,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

Insiders Place Their Bets

In other news, Director Troy A. Cooper bought 8,317 shares of the business’s stock in a transaction on Thursday, November 20th. The stock was purchased at an average price of $10.61 per share, with a total value of $88,243.37. Following the transaction, the director directly owned 275,416 shares in the company, valued at approximately $2,922,163.76. The trade was a 3.11% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Thomas A. Szlosek purchased 20,308 shares of the stock in a transaction dated Friday, November 7th. The stock was acquired at an average cost of $12.37 per share, for a total transaction of $251,209.96. Following the completion of the transaction, the director owned 36,508 shares of the company’s stock, valued at $451,603.96. The trade was a 125.36% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 40,250 shares of company stock valued at $488,875 in the last quarter. Insiders own 2.80% of the company’s stock.

Analysts Set New Price Targets

RXO has been the subject of a number of recent research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of RXO in a research note on Monday, December 22nd. Stifel Nicolaus increased their price objective on RXO from $15.00 to $16.00 and gave the stock a “hold” rating in a report on Tuesday, December 16th. Zacks Research cut shares of RXO from a “hold” rating to a “strong sell” rating in a research note on Friday, January 9th. Morgan Stanley raised shares of RXO from an “equal weight” rating to an “overweight” rating and set a $19.00 target price for the company in a research report on Tuesday, November 11th. Finally, Citigroup dropped their price target on shares of RXO from $16.00 to $15.00 and set a “neutral” rating on the stock in a research note on Thursday, January 8th. Four research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $16.14.

RXO Stock Down 1.8%

Shares of RXO stock opened at $15.55 on Friday. Rxo Inc has a 12-month low of $10.43 and a 12-month high of $26.92. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.24. The stock has a 50 day moving average price of $13.68 and a two-hundred day moving average price of $15.27. The stock has a market capitalization of $2.55 billion, a P/E ratio of -36.15, a PEG ratio of 7.73 and a beta of 1.74.

RXO (NYSE:RXO) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.44 billion. RXO had a positive return on equity of 0.88% and a negative net margin of 1.25%.RXO’s quarterly revenue was up 34.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.05 earnings per share. Equities analysts expect that Rxo Inc will post 0.31 earnings per share for the current year.

About RXO

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.